propranolol has been researched along with Anochlesia in 7 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " tardive dyskinesia) treatment with antipsychotics, including haloperidol, varies substantially among people." | 3.85 | Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms. ( Miksys, S; Nobrega, JN; Remington, G; Tolledo, EC; Tyndale, RF; Wadji, FB, 2017) |
| "Haloperidol-treated rats had higher bolus counts than vehicle-treated rats, and this increase was significantly reversed by the lipophilic but not the hydrophilic beta-antagonists." | 1.30 | The effects of beta-adrenoceptor antagonists on a rat model of neuroleptic-induced akathisia. ( Sachdev, PS; Saharov, T, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miksys, S | 1 |
| Wadji, FB | 1 |
| Tolledo, EC | 1 |
| Remington, G | 1 |
| Nobrega, JN | 1 |
| Tyndale, RF | 1 |
| Hara, C | 1 |
| Watanabe, S | 1 |
| Ueki, S | 1 |
| Sachdev, PS | 1 |
| Saharov, T | 1 |
| Bantutova, I | 1 |
| Honma, T | 1 |
| Fukushima, H | 1 |
| Ono, N | 1 |
| Saito, R | 1 |
| Abiru, T | 1 |
| Kamiya, H | 1 |
| Furukawa, T | 1 |
| Boissier, JR | 1 |
| Simon, P | 1 |
| Giudicelli, JF | 1 |
7 other studies available for propranolol and Anochlesia
| Article | Year |
|---|---|
Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms.
Topics: Animals; Brain; Catalepsy; Cytochrome P450 Family 2; Haloperidol; Liver; Male; Microinjections; Nico | 2017 |
Anti-muricide mechanisms of chlorpromazine and imipramine in OB rats: adrenoceptors and hypothalamic functions.
Topics: Aggression; Animals; Catalepsy; Chlorpromazine; Electroencephalography; Humans; Hypothalamus; Imipra | 1984 |
The effects of beta-adrenoceptor antagonists on a rat model of neuroleptic-induced akathisia.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Arousal; Catale | 1997 |
[Effect of pharmacological agents and coagulation of the n. raphe dorsalis on morphine effects].
Topics: Animals; Brain Stem; Catalepsy; Cyproheptadine; Dimenhydrinate; Electrocoagulation; Female; Fencloni | 1979 |
Role of brain norepinephrine in neuroleptic-induced catalepsy in rats.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Brain Chemistry; Butyrophenone | 1977 |
Possible involvement of prostaglandins in cataleptic behavior in rats.
Topics: Animals; Brain; Catalepsy; Dinoprost; Dinoprostone; Injections, Intraventricular; Male; Propranolol; | 1986 |
[Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
Topics: Animals; Apomorphine; Blepharoptosis; Bretylium Compounds; Catalepsy; Central Nervous System; Chlorp | 1968 |